# Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study

> **NCT04173208** · NA · UNKNOWN · sponsor: **Helsinki University Central Hospital** · enrollment: 90 (actual)

## Conditions studied

- Fecal Microbiota Transplantation
- Cesarean Section, Affecting Fetus or Newborn
- Intestinal Microbiome

## Interventions

- **OTHER:** Fecal microbial transplant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04173208
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-10
- **Primary completion:** 2024-01-16
- **Final completion:** 2025-01-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173208, "Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04173208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*